Skip to content
Home/Companies/Biotech/Opsona Therapeutics

Opsona Therapeutics

Biotech·Ireland·Exited 2019·Held 6yr
Entry
2013
Hold
6yr
Exit
2019

Who owns Opsona Therapeutics?

Opsona Therapeutics was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures III (2007 vintage) from 2013 to 2019.

Hand-verified · updated 2026-08-18

Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQIreland
SectorBiotech
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2019

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Follicum
Exited 2014
BiotechSweden· 2012
to
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011
Vaximm
Exited 2022
BiotechGermany· 2011
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Opsona Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Opsona Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Opsona Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue